News

Stocktwits on MSN1h
Hims & Hers Stock Drops After Evernorth Announces Cheaper Pricing For Weight-Loss Drugs: Retail’s Dull
Shares of telehealth provider Hims & Hers Health Inc. (HIMS) dropped over 3% on Thursday after Cigna Group’s (CI) Evernorth ...
Managed Healthcare Executive3h
Evernorth to Cap Out-of-Pocket Cost for Wegovy and Zepbound at $200
Health plan sponsors are also expected to see a reduction in the net cost per prescription of GLP-1 medications to treat obesity.
ConsumerAffairs2h
Do weight loss injections work?
Weight loss injections work by making you feel fuller and less hungry. There are plenty of weight loss medication options to ...
Novo Nordisk is betting on a CEO shake-up to regain its weight loss drug edge over Eli Lilly
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
Weight-loss company Noom pivots to smaller doses of compounded Wegovy
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
What happens to your weight after stopping Ozempic, Wegovy or Mounjaro?
Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...
Eli Lilly: Obesity Drug Development To Go Beyond That Of Zepbound
Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...
Ozempic Drugmaker’s CEO Pushed Out Amid Weight-Loss Market Challenges
Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...